|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2002-3-5
|
|
pubmed:abstractText |
Platelets have been suggested to play a role in the early development of atherosclerosis. As one test of this hypothesis, we assessed whether patients with Glanzmann thrombasthenia who lack platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) complexes or both alpha(IIb)beta(3) and the more ubiquitous alpha(v)beta(3) cell membrane complexes are protected from development of atherosclerosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
5
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1044-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11877352-Aged,
pubmed-meshheading:11877352-Apolipoproteins E,
pubmed-meshheading:11877352-Carotid Arteries,
pubmed-meshheading:11877352-Carotid Artery Diseases,
pubmed-meshheading:11877352-European Continental Ancestry Group,
pubmed-meshheading:11877352-Female,
pubmed-meshheading:11877352-Homozygote,
pubmed-meshheading:11877352-Humans,
pubmed-meshheading:11877352-Hyperlipidemias,
pubmed-meshheading:11877352-Lipids,
pubmed-meshheading:11877352-Lipoproteins,
pubmed-meshheading:11877352-Male,
pubmed-meshheading:11877352-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:11877352-Middle Aged,
pubmed-meshheading:11877352-Oxidoreductases Acting on CH-NH Group Donors,
pubmed-meshheading:11877352-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:11877352-Receptors, Vitronectin,
pubmed-meshheading:11877352-Reference Values,
pubmed-meshheading:11877352-Risk Factors,
pubmed-meshheading:11877352-Thrombasthenia
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis.
|
|
pubmed:affiliation |
Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
